Pharma Journalist -

Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA) accepted for Priority Review the company’s Biologics License Application (BLA) for TicoVac, its tick-borne…
Read More...

Adaptive Biotechnologies Corporation a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and…
Read More...

UCB and Microsoft have announced a new multi-year, strategic collaboration to combine Microsoft's computational services, cloud, and artificial intelligence (AI) with UCB's drug…
Read More...

SMi Group Reports: The 4th Annual Pharmaceutical Microbiology West Coast Conference will convene virtually on June 17th – 18th 2021 with two pre-conference interactive workshops on June…
Read More...

SIRION Biotech GmbH, a world leader in viral vector-based gene delivery technologies for gene & cell therapy, announced that it signed a license and collaboration agreement with…
Read More...

Compugen Ltd. a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, announced the expansion of its clinical collaboration agreement with Bristol…
Read More...

On February 21, 2021, GenScript ProBio and SunRock Biopharma, a company focused on the development of antibody therapeutics targeting cancer, announced a collaboration spanning…
Read More...

Novavax, Inc. a biotechnology company developing next-generation vaccines for serious infectious diseases, announced the complete enrollment of PREVENT-19, its pivotal Phase 3 study in…
Read More...

Sanofi and GlaxoSmithKline (GSK) announced the initiation of a new Phase 2 study with 720 volunteers aged 18 and over to select the most appropriate antigen dosage for Phase 3…
Read More...

AstraZeneca announced the voluntary withdrawal of the Imfinzi (durvalumab) indication in the US for previously treated adult patients with locally advanced or metastatic bladder cancer.…
Read More...